Premium
Activation of the E3 ligase function of the BRCA1/BARD1 complex by polyubiquitin chains
Author(s) -
Mallery Donna L.,
Vandenberg Cassandra J.,
Hiom Kevin
Publication year - 2002
Publication title -
the embo journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.484
H-Index - 392
eISSN - 1460-2075
pISSN - 0261-4189
DOI - 10.1093/emboj/cdf691
Subject(s) - ubiquitin ligase , ubiquitin , biology , dna ligase , microbiology and biotechnology , ring finger , nucleosome , histone , ubiquitin protein ligases , dna repair , ubiquitin conjugating enzyme , zinc finger , genetics , dna , transcription factor , gene
Loss of the tumour suppressor BRCA1 results in profound chromosomal instability. The fundamental defect underlying this catastrophic phenotype is not yet known. In vivo , BRCA1 forms a heterodimeric complex with BARD1. Both proteins contain an N‐terminal zinc RING‐finger domain which confers E3 ubiquitin ligase activity. We have isolated full‐length human BRCA1/BARD1 complex and have shown that it has a dual E3 ubiquitin ligase activity. First, it mediates the monoubiquitylation of nucleosome core histones in vitro , including the variant histone H2AX that co‐localizes with BRCA1 at sites of DNA damage. Secondly, BRCA1/BARD1 catalyses the formation of multiple polyubiquitin chains on itself. Remarkably, this auto‐polyubiquitylation potentiates the E3 ubiquitin ligase activity of the BRCA1/BARD1 complex >20‐fold. Even though BRCA1 has been reported to associate with a C‐terminal ubiquitin hydrolase, BAP1, this enzyme does not appear to function in the deubiquitylation of the BRCA1/BARD1 complex.